DaVita Inc. (NYSE:DVA) Shares Acquired by Moran Wealth Management LLC

Moran Wealth Management LLC increased its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 6.2% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 117,204 shares of the company's stock after acquiring an additional 6,882 shares during the period. Moran Wealth Management LLC owned approximately 0.15% of DaVita worth $17,929,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DVA. UMB Bank n.a. grew its holdings in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management purchased a new stake in DaVita in the 4th quarter valued at about $30,000. SBI Securities Co. Ltd. acquired a new position in DaVita in the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC boosted its stake in DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares during the period. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in shares of DaVita during the fourth quarter valued at about $55,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Truist Financial lowered their price target on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DaVita currently has a consensus rating of "Hold" and a consensus price target of $164.50.

DaVita Stock Up 0.3%

DaVita stock traded up $0.48 during mid-day trading on Friday, reaching $141.57. 313,574 shares of the company's stock were exchanged, compared to its average volume of 802,439. The company has a fifty day moving average of $139.43 and a 200-day moving average of $149.61. The company has a market cap of $10.69 billion, a P/E ratio of 14.02, a P/E/G ratio of 0.97 and a beta of 1.11. The company has a quick ratio of 1.20, a current ratio of 1.25 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter last year, the company earned $2.26 earnings per share. The firm's revenue was up 5.0% compared to the same quarter last year. Sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.